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Cardiac Computed Tomographic Angiography for Detection
of Cardiac Sources of Embolism in Stroke Patients
Jin Hur, MD; Young Jin Kim, MD; Hye-Jeong Lee, MD; Jong-Won Ha, MD; Ji Hoe Heo, MD;
Eui-Young Choi, MD; Chi-Young Shim, MD; Tae Hoon Kim, MD; Ji Eun Nam, MD;
Kyu Ok Choe, MD; Byoung Wook Choi, MD
Background and Purpose—We assessed the diagnostic performance of 2-phase 64-slice cardiac computed tomographic
angiography (CCTA) for the detection of a cardiac source of embolism in stroke patients using transesophageal
echocardiography (TEE) as the reference standard.
Methods—We selected 137 patients who had experienced a recent episode of stroke and had undergone both 2-phase
64-slice CCTA and TEE within a period of 5 days. A potential cardiac source of embolism detected at both CCTA and
TEE was recorded, and echocardiographic findings were categorized into high- and medium-risk sources based on the
TOAST (Trial of Org 10172 in Acute Stroke Treatment) classification.
Results—Of 137 patients, 100 abnormal findings in 91 patients were found on TEE, and 46 patients had no abnormal
finding on TEE. The overall sensitivity, specificity, positive predictive value, and negative predictive value of the
64-slice CCTA for detecting cardiac sources of embolism were 89% (95% CI, 82%, 95%), 100% (95% CI, 90%, 100%),
100% (95% CI, 95%, 100%), and 81% (95% CI, 70%, 92%), respectively. TEE detected a total of 47 high-risk sources
of embolism, whereas CT detected 44 lesions. For medium-risk sources of cardiac embolic stroke, TEE detected a total
of 53 abnormal findings, whereas CT detected 44 abnormal findings. Of 53 lesions, there were 8 false-negative results
on CT (5 patent foramen ovale and 3 atrial septal aneurysm).
Conclusions—Two-phase 64-slice CCTA is a noninvasive and useful modality for detecting high-risk cardiac sources of
embolism in stroke patients. (Stroke. 2009;40:2073-2078.)
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Cardiogenic emboli have been estimated to be the caus-ative factor in 20% to 40% of all stroke cases.1 There-
fore, identification of a cardiac source of embolism in stroke
patients is important for proper therapeutic management.
Currently, transesophageal echocardiography (TEE) is
considered the reference standard method for the detection of
potential sources of cerebral embolism. TEE offers high-
resolution images of the left atrium (LA) and its appendage as
well as the thoracic aorta for the evaluation of left atrial blood
stasis and aortic atherosclerosis.2–4 Although TEE is widely
available, it is a semi-invasive test, usually performed under
conscious sedation.
Recently introduced 64-slice cardiac computed tomo-
graphic angiography (CCTA) with subsecond rotation times
and a dedicated cardiac reconstruction algorithm can acquire
3-dimensional data of the heart, enabling detailed visualiza-
tion of not only the coronary arteries but also other cardiac
structures such as the left atrial appendage (LAA), myocar-
dium, valves, and septa.5–8 By previous reports, CT has
shown its diagnostic capability in the detection of intracardiac
thrombi and patent foramen ovale (PFO).9–12
The aim of this study was to assess the diagnostic perfor-
mance of 2-phase 64-slice CCTA for the detection of a




Our Institutional Review Board approved this study, and patients
were provided with informed consent. From January 2008 to July
2008, 331 consecutive patients were admitted to our hospital for a
recent stroke (onset within the previous 7 days) and prospectively
enrolled in the current study. Of these patients, 248 patients
underwent TEE for suspected cardioembolic stroke within 1 week of
the initial stroke, except in patients (n83) with decreased con-
sciousness, impending brain herniation, poor systemic conditions,
tracheal intubations, or failure in receiving an esophageal transducer.
Of these, 142 patients, who had 2 risk factors for coronary artery
disease were prospectively enrolled to perform 2-phase CCTA for
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evaluation of coronary artery disease and potential cardiac embolic
sources. Five patients who had contrast agent allergy (n2), renal
dysfunction (n1), or failed to provide an informed consent (n2)
were excluded. Finally, the remaining 137 patients with 2 risk
factors for coronary artery disease were included. All examinations
were performed within a 5-day interval (mean, 2.8 days). All patients
underwent brain CT or brain MRI to characterize the stroke and to
exclude hemorrhages and other causes. The patients consisted of 91
men and 46 women, aged from 37 to 85 years (mean age, 61 years).
Baseline clinical characteristics, including systemic hypertension,
hyperlipidemia, diabetes mellitus, and smoking habits, were deter-
mined from medical records and routine laboratory data.
Subtypes of ischemic stroke were classified according to the
TOAST (Trial of Org 10172 in Acute Stroke Treatment) classifica-
tion system.13 Whereas the TOAST classification does not define
how to categorize a patient with aortic atheromas, which is a
significant cause of stroke, atheroma 4 mm in the ascending aorta
and aortic arch was classified as cardioembolism in this study.14 The
stroke subtypes of 331 patients were stroke of undetermined etiology
(n122, 40%), cardioembolism (n97, 29%), large artery athero-
sclerosis (n71, 21%), lacune (n36, 11%), and stroke of other
determined etiology (n6, 2%).
CCTA Examination
We performed 2-phase CCTA using a 64-slice helical CT (Sensation
64; Siemens Medical Solutions). The scan protocol included both an
early-phase scan to evaluate the coronary arteries, and cardioembolic
sources (eg, intracardiac thrombus, intracardiac shunt), and a late-
phase scan to differentiate between a thrombus and circulatory stasis
and to evaluate aortic atheromas. The mean laboratory testing of
BUN and creatinine of the 137 stroke patients were 11.5 mg/dL
(range, 7.4–19.8) and 0.94 mg/dL (range, 0.67–1.21), respectively.
There were no renal complications in all patients after 2-phase
CCTA examinations.
A -blocker (40 mg propranolol hydrochloride; Pranol; Dae
Woong) was administered orally to reduce the heart rate 1 to 2 hours
before examination in patients with a heart rate 65 beats per
minute. The mean heart rate was 6112 beats per minute (range,
51–87 bpm) during the CT examination. Contrast solution, com-
posed of 75 mL of nonionic contrast agent (370 iodine mg/mL;
Iopamiro; Bracco) chased by a 50-mL saline solution was adminis-
tered intravenously at a rate of 5 mL/sec using a power injector
(Envision CT; Medrad).
Early-phase scanning was started with a time delay determined by
the bolus-tracking technique using a region of interest in the
ascending aorta to monitor a threshold of 100 Hounsfield units
above the baseline attenuation. The following scan parameters were
used: 330-ms gantry rotation time, 120 kV, 800 mAs, 0.6-mm slice
collimation, 1-mm slice width, and 3.3-mm table feed/rotation to
cover the entire heart. The scan was acquired in a single breath-hold
using retrospective ECG gating.
Late-phase images were started 30 seconds later, after the end of
the early-phase scan. To reduce the radiation dose, we used the
following parameters: 300.6 mm, 120 kV, and 200 mAs to cover
the aortic arch to the middle of the left ventricle. The scan was
acquired using prospective ECG gating. The calculated radiation
dose was 6 to 8 mSv for early-phase imaging and 0.5 to 1 mSv for
late-phase imaging.
The reconstruction parameters were as follows: 0.8-mm slice
thickness, 0.5-mm increment, 512512 pixel image matrix, a
medium smooth kernel, and 18- to 20-cm field of view. The early-
and late-phase image sets were sent to the workstation (Wizard;
Siemens Medical Solutions) and reviewed by 2 cardiac radiologists.
In addition, axial and oblique sagittal multi-planar images perpen-
dicular to the atrial septum were reconstructed and evaluated at an
off-line workstation (AquarisNet Viewer V1.8.0.3; TeraRecon, Inc).
TEE
Transesophageal 2-dimensional and Doppler echocardiography was
performed by an experienced cardiologist with a 5-MHz, phased-
array transducer attached to the tip of a commercially available
gastroscope (Acuson/Siemens). For each patient, all images were
recorded as movie images on digital videotape in real-time for
display and evaluation. The images of the LA and the LAA were
evaluated in both the horizontal (0°) plane and the plane obtained by
rotation of the imaging sector from 0° to 180° during continuous
visualization of the LAA. All patients underwent intravenous agi-
tated saline injection with a Valsalva maneuver to exclude an
intracardiac shunt. At least 2 saline injections without a Valsalva
maneuver and 2 injections during the Valsalva maneuver were
performed, and images of the interatrial septum and right and left
atrium were recorded in each patient. All segments of the thoracic
aorta, including both the ascending/descending aorta and the aortic
arch, were evaluated for the presence of plaques between angles of
0° and 90°. Plaque thickness was defined as the thickness of the
intima and media layers of the walls measured perpendicularly
during systole on a frozen frame. The maximum thickness of the
plaques in each region was recorded.
Image Analysis
Two experienced cardiologists prospectively and independently
reviewed the TEE images of the 137 patients. In cases of disagree-
ment, a consensus was achieved by a joint reading.
The following echocardiographic abnormalities were considered a
possible cardiac source of embolism: LA or LAA thrombus, left
ventricle thrombus, cardiac tumors, valve vegetation, infective en-
Table 1. Clinical Characteristics of 137 Stroke Patients
Characteristics







Age, mean1 SD, yr 6113 6211 5912 0.578
Male 95 (69) 61 (69) 34 (72) 0.409
Hypertension 107 (78) 74 (81) 33 (71) 0.316
Hyperlipidemia 45 (33) 32 (35) 13 (28) 0.283
Diabetes mellitus 56 (41) 33 (36) 20 (44) 0.413
Smoking 42 (31) 24 (26) 18 (39) 0.126
History of CVA 25 (18) 15 (16) 10 (22) 0.452
Atrial fibrillation* 57 (42) 45 (49) 12 (26) 0.009
CVA indicates cerebrovascular accident.
*Fifty-seven patients (42%) were in AF at the time of their stroke and AF was more commonly
observed in patients with an abnormal finding on TEE.
Note: All except age data are numbers of patients, with the percentage of patients in parentheses.
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docarditis, spontaneous echo contrast (SEC), atrial septal defect,
PFO, atrial septal aneurysm (ASA), mitral annular calcification,
and aortic atheroma. Echocardiographic findings were catego-
rized into high- and medium-risk sources based on their relative
propensities for causing embolism according to the TOAST
classification system.13,14
In TEE, a thrombus was defined as a well-circumscribed, uni-
formly consistent, echo-reflective mass of a different texture from
the LA or LAA wall. Valvular vegetations were diagnosed as echo
densities on the mitral or aortic valves that had independent motion
as compared to the valve. SEC was characterized by dynamic clouds
of echoes curling slowly in a circular or spiral shape within the LAA
cavity. The severity of SEC was divided into 4 grades as follows:
none, the absence of this phenomenon; mild, minimal echogenicity
only transiently detectable with optimal gain settings transiently
during the cardiac cycle; moderate, dense swirling pattern during the
entire cardiac cycle; and severe, intense echodensity and very slow
swirling patterns in the LAA, usually with a similar density in the
main cavity. PFO was considered to be present if any microbubbles
were seen in the left-side cardiac chambers within 3 cardiac cycles of
the maximum right atrium opacification or if a turbulent color jet was
seen within the atrial septum on color Doppler. ASA was defined as
an abnormally redundant interatrial septum with an excursion of
10 mm and a base span 15 mm.15 Sessile aortic atheroma was
considered to be a discrete, nonmobile lesion 4 mm in the
ascending aorta, or the aortic arch.16
Two experienced radiologists prospectively and independently
reviewed the CCTA images of the 137 patients. Differences in
assessment were resolved by consensus. Each reader was blinded to
the results of other examinations and clinical data.
On CT, we defined a thrombus as a filling defect that appeared on
both early- and late-phase images with an oval or round shape on
late-phase images. Valvular vegetations were diagnosed as a filling
defect that appeared as an oval or round shape on both early- and
late-phase images on the mitral or aortic valve. Circulatory stasis
was defined as a filling defect that appeared as a triangular shape in
the LAA only on early-phase images but was absent on late-phase
images. PFO was defined as the presence of a contrast jet from the
contrast-filled LA to the saline-filled right atrium (RA) toward the
inferior vena cava (IVC) with a channel-like appearance of the interar-
terial septum.11,12 Atrial septal defect was defined as the presence of
a contrast jet from contrast-filled LA to the saline-filled right atrium
perpendicular to the septum without the channel-like appearance of
an interarterial septum. ASA was defined as an abnormally bulging
of the interatrial septum with an excursion of 10 mm and a base
span 15 mm. Sessile atheroma was considered to be a discrete,
nonmobile lesion 4 mm in the ascending aorta or the aortic arch.
Statistical Analysis
Categorical baseline characteristics were expressed as numbers and
percentages, and were compared between 2 groups with the 2 test.
Continuous variables were expressed as mean (SD) and were
compared with the Student t test for independent samples.
For all imaging modalities, we recorded the number of the
detected cardiac sources of embolism. Using TEE as the reference
standard, the sensitivity, specificity, positive predictive value (PPV)
and negative predictive value (NPV) of CCTA for detecting cardiac
sources of embolism were calculated; 95% CI were calculated by
using the method of exact binomial tail areas.17 The analysis was
performed on a per-lesion and per-patient basis. On a per-patients
analysis, patients with both high- and medium-risk sources were
categorized as high-risk sources.
All statistical analyses were performed with SPSS software
(Version 10.0; Statistical Package for the Social Sciences).
Results
The image quality of all CCTA examinations was considered
acceptable for the evaluation of intracardiac abnormalities.
However, there were some nonassessable segments for eval-
Table 2. Potential Cardiac Sources of Embolism in 137 Stroke







Cardiac tumor 0 0
Valvular vegetation 1 2
Infective endocarditis 0 0
Aortic atheroma (AA or arch) 31 33
Medium risk sources
Circulatory stasis/SEC† 15 15
PFO‡/ASD 17 (14/3) 22 (19/3)
ASA 8 11
Mitral annular calcification 5 5
No abnormality 57 46
AA indicates ascending aorta.
*Includes thrombus combined with circulatory stasis.
†Includes circulatory stasis without thrombus.
‡Includes 4 PFO combined with ASA.
Table 3. CT Results in the Detection of Potential Cardiac Sources of Embolism
in 137 Stroke Patients (per Lesion and per Patient Analyses)
Cardiac Sources
All High-Risk Medium-Risk
Lesions Patients Lesions Patients* Lesions Patients
True-positive 89 85 44 45 45 40
True-negative 46 46 46 46 46 46
False-positive 0 0 0 0 0 0
False-negative 11 6 3 2 8 4
Sensitivity (%) 89 93 94 96 83 91
Specificity (%) 100 100 100 100 100 100
PPV (%) 100 100 100 100 100 100
NPV (%) 81 88 94 96 84 92
*In a per-patient analysis, patients with both high- and medium-risk sources were categorized as
high-risk sources.
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uation of the coronary arteries, especially in patients with
atrial fibrillation (AF).
The clinical characteristics of the 137 patients are summa-
rized in Table 1. Of these 137 patients, 100 abnormal findings
in 91 patients were found on TEE. Furthermore, 10 patients
had 1 abnormal finding, and 46 patients had no abnormal
finding on TEE. Clinical characteristics were not significantly
different between patients with and without abnormal TEE
findings except for those in AF. Fifty-seven patients (42%) were
in AF at the time of their stroke. AF was more commonly
observed in patients with an abnormal finding on TEE.
The potential cardiac sources of embolism detected by
TEE and CT are summarized in Table 2. On TEE, 100
abnormal findings were detected in 91 patients, whereas 89
abnormal findings were detected in 91 patients by CT,
including 11 false-negative results (Table 2). Using TEE as
the reference standard, the overall sensitivity, specificity,
PPV, and NPV of the 64-slice CCTA for detecting cardiac
sources of embolism were 89% (95% CI, 82%, 95%), 100%
(95% CI, 90%, 100%), 100% (95% CI, 95%, 100%), and
81% (95% CI, 70%, 92%), respectively (Table 3).
In a per-patient analysis, 91 stroke patients had at least 1
abnormal finding on TEE. Of these 91 patients, 6 patients had
missed cardiac embolic sources with CT. Therefore, using
TEE as the reference standard, the overall sensitivity, speci-
ficity, PPV, and NPV of the 64-slice CCTA for detecting
cardiac sources of embolism were 93% (95% CI, 87%, 99%),
100% (95% CI, 90%, 100%), 100% (95% CI, 95%, 100%),
and 88% (95% CI, 78%, 98%), respectively (Table 3).
For the detection of high-risk sources for cardiac embolic
stroke, TEE detected a total of 47 abnormal findings, whereas
CT detected 44 abnormal findings (Table 2). Using TEE as
the reference standard, the sensitivity, specificity, PPV, and
NPV of the 64-slice CCTA for detecting high-risk cardiac
sources of embolism were 94% (95% CI, 86%, 100%), 100%
(95% CI, 90%, 100%), 100% (95% CI, 90%, 100%), and
94% (95% CI, 91%, 100%), respectively (Table 3).
In a per-patient analysis, 47 patients had at least 1 high-risk
source on TEE. Of these 47 patients, 2 patients had missed
cardiac embolic sources with CT. Using TEE as the reference
standard, the overall sensitivity, specificity, PPV, and NPV of
the 64-slice CCTA for detecting cardiac sources of embolism
were 96% (95% CI, 89%, 100%), 100% (95% CI, 90%,
100%), 100% (95% CI, 90%, 100%), and 96% (95% CI,
89%, 100%), respectively (Table 3).
TEE detected a total of 12 thrombi (11 located in the LAA
and 1 located in the LA). On CCTA, a total of 12 filling
defects (11 filling defects in the LAA and 1 filling defect in
the LA) showed persistent filling defects on both early- and
delayed-phase images, which is a typical finding of thrombus
(Figure 1). Of the 47 lesions, there were 3 false-negative results
on CT. One of the mitral valve vegetations was misdiagnosed as
mitral valve thickening on CT. Two aortic atheromas in the
aortic arch were not considered high-risk sources by CT because
the size of atheromas measured by CT was 4 mm.
For the detection of medium-risk sources of cardiac em-
bolic stroke, TEE detected a total of 53 abnormal findings,
whereas CT detected 45 abnormal findings (Table 2). Using
TEE as the reference standard, the sensitivity, specificity,
PPV, and NPV of the 64-slice CCTA for detecting medium-
risk cardiac sources of embolism were 83% (95% CI, 71%,
94%), 100% (95% CI, 90%, 100%), 100% (95% CI, 90%,
100%) and 84% (95% CI, 73%, 95%), respectively (Table 3).
In a per-patient analysis, 44 patients had medium-risk
sources on TEE. Of these 44 patients, 4 patients had missed
cardiac embolic sources with CT. Using TEE as the reference
standard, the overall sensitivity, specificity, PPV, and NPV of
the 64-slice CCTA for detecting cardiac sources of embolism
were 91% (95% CI, 81%, 100%), 100% (95% CI, 90%,
100%), 100% (95% CI, 89%, 100%), and 92% (95% CI,
83%, 100%), respectively (Table 3).
On TEE, there was a total of 15 SEC, and all were correctly
detected by 2-phase 64-slice CCTA. By CT, all SEC detected
on TEE showed typical finding of a filling defect that
appeared as a triangular shape in the LAA only on early-phase
Figure 2. CCTA and TEE images in a
65-year-old man who experienced a stroke
with SEC. A, Early-phase CCTA demon-
strates triangular-shape filling defects in the
LAA (arrows). B, Late-phase CCTA demon-
strates no filling defects in the LAA (arrows).
C, TEE image obtained 1 day after CCTA.
TEE demonstrates moderate SEC without
any thrombus in the LAA.
Figure 1. CCTA and TEE images in a 62-year-old man with stroke and LAA thrombus. A and B, Early- and late-phase CCTA demon-
strate an oval-shape filling defect in the LAA (large arrow) with circulatory stasis (small arrows) just distal to the thrombus. A filling
defect just distal to the thrombus caused by circulatory stasis disappears on late-phase imaging. C, TEE image obtained 1 day after
CCTA. TEE demonstrates a thrombus (large arrow) with circulatory stasis just distal to the thrombus (small arrows).
2076 Stroke June 2009
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images but was absent on late-phase images (Figure 2). Of the
15 filling defects diagnosed correctly as circulatory stasis with-
out thrombus by CT, SEC was categorized as severe in 6 cases,
moderate in 7 cases, and mild in 2 cases. TEE detected a total of
19 PFO and 3 atrial septal defects. Fifteen of 19 patients had
PFO diagnosed by the showing of microbubbles on the left-side
cardiac chambers within 3 cardiac cycles of the maximum right
atrium opacification after agitated saline injection, whereas 4 of
19 cases were diagnosed by a showing of a turbulent color jet
within the interarterial septum on Doppler TEE, even though no
microbubbles were seen. On CT, LA to right atrium contrast jet
toward the inferior vena cava was found in 14 patients, and contrast
jet perpendicular to the septum was found in 3 patients (Figure 3).
All 3 atrial septal defects were correctly diagnosed by CT. How-
ever, of the 19 PFO, 14 lesions were correctly diagnosed by CT
(73%, 14 of 19). Four PFO were combined with ASA, and 3 of 4
lesions were correctly diagnosed by CT. Of the 11 ASA, 8 lesions
were correctly diagnosed by CT (73%, 8 of 11; Figure 4).
Discussion
This study demonstrates that 2-phase 64-slice CCTA is a
useful modality for the detection of cardiac sources of embo-
lism in stroke patients. The diagnostic performance for the
detection of high-risk cardiac sources of embolism by 2-phase
64-slice CCTA was excellent and comparable to TEE.
In our study, we categorized cardiac sources of embolism
detected on TEE into high- and medium-risk sources accord-
ing to the TOAST classification systems. The TOAST clas-
sification system defines high- and medium- risk cardiac
sources based on their relative propensities for causing an
embolism.13,14 For high-risk embolic sources, anticoagulation
is an indication for therapeutic management; however,
medium-risk sources have more modest or undefined risks
and little randomized comparative evidence to guide manage-
ment. Therefore, in determining the effectiveness of thera-
peutic management, the detection of high-risk cardiac sources
is more important.14,18
In our study, 2-phase CCTA showed high sensitivity (94%)
and high specificity (100%) in the detection of high-risk
cardiac sources as compared with TEE. The highly accurate
diagnostic performance strongly suggests that 2-phase CCTA
could be useful in the detection of high-risk cardiac sources of
embolism in stroke patients. Although there were 3 false-
negative results, the 12 thrombi diagnosed by TEE were all
correctly diagnosed by CCTA.
For the detection of medium-risk sources, the diagnostic
yield of CT was lower compared to TEE, especially for
diagnosing PFO. Recently, there have been a few reports11,12
on the multi-detector row CT findings of a PFO that were
channel-like appearances of the interarterial septum and
left-to-right interatrial shunt. In our study, LA to right atrium
contrast jet toward the inferior vena cava was found in 14
patients on CT, and all these patients had PFO diagnosed with
TEE. We believe that the lower sensitivity for diagnosing
PFO by CT is caused by the fundamentally different princi-
ples for diagnosing PFO between TEE and CT. TEE diag-
noses of PFO were made by detecting momentary right-to-
left shunts with a provocative maneuver, whereas CT
diagnoses were made by detecting a left-to-right shunt in the
resting state. Therefore, in diagnosing PFO, CT has its
limitation in that although routine cardiac CT during the
resting state can anatomically detect PFO, it fails to analyze
the functional aspects of PFO by pointing out the clinically
significant cases. For example, PFO with high membrane
mobility and right-to-left shunting at rest are more associated
with cryptogenic stroke.19
Figure 4. CCTA and TEE images in a 51-year-
old woman with stroke with ASA. A, CCTA
demonstrates an abnormal bulging of the inter-
atrial septum from the LA to the right atrium
(arrows). B, TEE demonstrates an abnormal
bulging of the interatrial septum from the LA to
the right atrium (arrows).
Figure 3. CCTA and TEE images in a 47-year-old man with stroke with a PFO. A and B, Axial and oblique sagittal reformation CCTA images dem-
onstrate the channel-like appearance of the interatrial septum (arrow) and contrast jets from the LA to the right atrium toward the inferior vena cava
(arrow). C, TEE with agitated saline injection and Valsalva maneuver reveals a shunt from the right atrium to the LA through the appearance of
microbubbles (arrows) in the left atrium.
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In our study, the diagnostic yield of CT for detection of
thrombus, aortic atheroma, and SEC were high, which can be
anatomically detected by CT. However, the diagnostic yield
for detection of PFO or ASA was lower by CT as compared
to TEE, which need provocative maneuver for their diagno-
sis. This result suggests that CT can have limitation in the
detection of cardioembolic sources, especially in younger
stroke patients, because it is known that the incidence of PFO,
ASA, or a combination of both are higher in younger stroke
patients or with cryptogenic stroke.19,20
For many cardiac risk sources of embolism, referred to as
medium-risk sources, the optimal choice of therapy is not
clear. At present, there is not enough evidence in the literature
to recommend anticoagulation therapy over aspirin in patients
with medium-risk factors; therefore, TEE does not provide
therapeutic gains in terms of medical treatment.21–24 Further-
more, the diagnostic performance of the CCTA for detecting
medium-risk sources was improved in a per-patient analysis.
In that respect, we believe that 2-phase CCTA can be used as
a screening test for detecting potential cardiac sources of
embolism in selected stroke patients before TEE, because it
has high diagnostic accuracy in the detection of high-risk
cardiac sources of embolism and is a noninvasive modality.
Our study had several limitations. First, we did not perform
CCTA studies in all stroke patients who underwent TEE. For
CCTA indication, we selected patients who had 2 risk
factors for coronary artery disease. This would potentially
yield an older stroke population with increased likelihood that
CCTA would identify high-risk sources of embolism, such as
aortic plaques. It is known that the prevalence of medium-risk
sources would be expected to be higher in a younger
population.19,20 Therefore, the frequencies of some cardiac
sources of embolism, particularly those that are dependent on
echocardiographic studies, could be underestimated and the
overall results could be affected. Second, we did not perform the
2 examinations on the same day. All examinations were per-
formed within a 5-day interval to evaluate for intracardiac
sources of embolism. A further limitation was radiation expo-
sure. Although we performed 2-phase imaging, we used pro-
spective ECG gating and lowered the mAs to 200 for the
late-phase imaging to reduce the radiation dose. Therefore, the
additional radiation dose for late-phase imaging was small.
Conclusion
Two-phase 64-slice CCTA is a useful modality for detecting
potential cardiac sources of embolism in stroke patients. In
addition, 2-phase CCTA exhibits excellent diagnostic perfor-
mance in the detection of high-risk cardiac sources of
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